Vénásthromboembolia-kockázati kérdoív kórházban kezelt sebészeti és nem sebészeti betegek részére .,A thromboemboliák kockázatá nak csökkentése és kezelése" címu, 4. magyar antithromboticus irányelvben

Marianna Dávid, Hajna Losonczy, Miklós Udvardy, Zoltán Boda, György Blaskó, Attila Tar, György Pfliegler

Research output: Article

2 Citations (Scopus)

Abstract

A large proportion of hospitalized surgical and medical patients are at risk for venous thromboembolism. Depending on the type of surgical intervention, venous thrombosis develops in 15-60% of surgical patients without prophylaxis. Although venous thromboembolism is most often considered to be associated with recent surgery or trauma, 50 to 70% of symptomatic thromboembolic events and 70 to 80% of fatal pulmonary embolisms occur in nonsurgical patients. International and national registries show that the majority of at-risk surgical patients actually received the appropriate thromboembolic prophylaxis. However, despite of international and national recommendations, prophylaxis was not provided for a large proportion of at-risk medical patients. The rate of medical patients receiving prophylaxis should be increased, and appropriate thrombosis prophylaxis should be offered to at-risk medical patients. The thrombosis risk assessment is an important tool to identify patients at increased risk for venous thromboembolism, to simplify decision making on prophylaxis administration, and to improve the adherence to guidelines. When the risk is recognized, if there is no contraindication, prophylaxis should be ordered. The 4th Hungarian Antithrombotic Guideline entitled "Risk reduction and treatment of thromboembolism" calls attention to the importance of risk assessment and for the first time it includes and recommends risk assessment models for hospitalized surgical and medical patients. The risk assessment models are presented and the evidence based data for the different risk factors included in these models are reviewed.

Original languageHungarian
Pages (from-to)1365-1374
Number of pages10
JournalOrvosi Hetilap
Volume151
Issue number34
DOIs
Publication statusPublished - aug. 1 2010

Fingerprint

Venous Thromboembolism
Guidelines
Therapeutics
Thrombosis
Guideline Adherence
Anatomic Models
Thromboembolism
Risk Reduction Behavior
Pulmonary Embolism
Venous Thrombosis
Registries
Decision Making
Wounds and Injuries

Keywords

  • risk assessment
  • thrombosis prophylaxis
  • thrombosis risk
  • venous thromboembolism

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{c7264ea7088243059d6ef020d2cb7974,
title = "V{\'e}n{\'a}sthromboembolia-kock{\'a}zati k{\'e}rdo{\'i}v k{\'o}rh{\'a}zban kezelt seb{\'e}szeti {\'e}s nem seb{\'e}szeti betegek r{\'e}sz{\'e}re .,A thromboemboli{\'a}k kock{\'a}zat{\'a} nak cs{\"o}kkent{\'e}se {\'e}s kezel{\'e}se{"} c{\'i}mu, 4. magyar antithromboticus ir{\'a}nyelvben",
abstract = "A large proportion of hospitalized surgical and medical patients are at risk for venous thromboembolism. Depending on the type of surgical intervention, venous thrombosis develops in 15-60{\%} of surgical patients without prophylaxis. Although venous thromboembolism is most often considered to be associated with recent surgery or trauma, 50 to 70{\%} of symptomatic thromboembolic events and 70 to 80{\%} of fatal pulmonary embolisms occur in nonsurgical patients. International and national registries show that the majority of at-risk surgical patients actually received the appropriate thromboembolic prophylaxis. However, despite of international and national recommendations, prophylaxis was not provided for a large proportion of at-risk medical patients. The rate of medical patients receiving prophylaxis should be increased, and appropriate thrombosis prophylaxis should be offered to at-risk medical patients. The thrombosis risk assessment is an important tool to identify patients at increased risk for venous thromboembolism, to simplify decision making on prophylaxis administration, and to improve the adherence to guidelines. When the risk is recognized, if there is no contraindication, prophylaxis should be ordered. The 4th Hungarian Antithrombotic Guideline entitled {"}Risk reduction and treatment of thromboembolism{"} calls attention to the importance of risk assessment and for the first time it includes and recommends risk assessment models for hospitalized surgical and medical patients. The risk assessment models are presented and the evidence based data for the different risk factors included in these models are reviewed.",
keywords = "risk assessment, thrombosis prophylaxis, thrombosis risk, venous thromboembolism",
author = "Marianna D{\'a}vid and Hajna Losonczy and Mikl{\'o}s Udvardy and Zolt{\'a}n Boda and Gy{\"o}rgy Blask{\'o} and Attila Tar and Gy{\"o}rgy Pfliegler",
year = "2010",
month = "8",
day = "1",
doi = "10.1556/OH.2010.28944",
language = "Hungarian",
volume = "151",
pages = "1365--1374",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "34",

}

TY - JOUR

T1 - Vénásthromboembolia-kockázati kérdoív kórházban kezelt sebészeti és nem sebészeti betegek részére .,A thromboemboliák kockázatá nak csökkentése és kezelése" címu, 4. magyar antithromboticus irányelvben

AU - Dávid, Marianna

AU - Losonczy, Hajna

AU - Udvardy, Miklós

AU - Boda, Zoltán

AU - Blaskó, György

AU - Tar, Attila

AU - Pfliegler, György

PY - 2010/8/1

Y1 - 2010/8/1

N2 - A large proportion of hospitalized surgical and medical patients are at risk for venous thromboembolism. Depending on the type of surgical intervention, venous thrombosis develops in 15-60% of surgical patients without prophylaxis. Although venous thromboembolism is most often considered to be associated with recent surgery or trauma, 50 to 70% of symptomatic thromboembolic events and 70 to 80% of fatal pulmonary embolisms occur in nonsurgical patients. International and national registries show that the majority of at-risk surgical patients actually received the appropriate thromboembolic prophylaxis. However, despite of international and national recommendations, prophylaxis was not provided for a large proportion of at-risk medical patients. The rate of medical patients receiving prophylaxis should be increased, and appropriate thrombosis prophylaxis should be offered to at-risk medical patients. The thrombosis risk assessment is an important tool to identify patients at increased risk for venous thromboembolism, to simplify decision making on prophylaxis administration, and to improve the adherence to guidelines. When the risk is recognized, if there is no contraindication, prophylaxis should be ordered. The 4th Hungarian Antithrombotic Guideline entitled "Risk reduction and treatment of thromboembolism" calls attention to the importance of risk assessment and for the first time it includes and recommends risk assessment models for hospitalized surgical and medical patients. The risk assessment models are presented and the evidence based data for the different risk factors included in these models are reviewed.

AB - A large proportion of hospitalized surgical and medical patients are at risk for venous thromboembolism. Depending on the type of surgical intervention, venous thrombosis develops in 15-60% of surgical patients without prophylaxis. Although venous thromboembolism is most often considered to be associated with recent surgery or trauma, 50 to 70% of symptomatic thromboembolic events and 70 to 80% of fatal pulmonary embolisms occur in nonsurgical patients. International and national registries show that the majority of at-risk surgical patients actually received the appropriate thromboembolic prophylaxis. However, despite of international and national recommendations, prophylaxis was not provided for a large proportion of at-risk medical patients. The rate of medical patients receiving prophylaxis should be increased, and appropriate thrombosis prophylaxis should be offered to at-risk medical patients. The thrombosis risk assessment is an important tool to identify patients at increased risk for venous thromboembolism, to simplify decision making on prophylaxis administration, and to improve the adherence to guidelines. When the risk is recognized, if there is no contraindication, prophylaxis should be ordered. The 4th Hungarian Antithrombotic Guideline entitled "Risk reduction and treatment of thromboembolism" calls attention to the importance of risk assessment and for the first time it includes and recommends risk assessment models for hospitalized surgical and medical patients. The risk assessment models are presented and the evidence based data for the different risk factors included in these models are reviewed.

KW - risk assessment

KW - thrombosis prophylaxis

KW - thrombosis risk

KW - venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=77955621533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955621533&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28944

DO - 10.1556/OH.2010.28944

M3 - Article

C2 - 20705551

AN - SCOPUS:77955621533

VL - 151

SP - 1365

EP - 1374

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 34

ER -